Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04551352
Title A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DNK | CAN | BEL | AUS

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Thomas Jefferson University Hospital;Medical Oncology Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Peter Maccallum Cancer Institute; Clinical Trial Unit Melbourne Victoria 3000 Australia Details
UZ Antwerpen Edegem 2650 Belgium Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
The Ottawa Hospital - General Campus Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 1Z5 Canada Details
Herlev Hospital; Afdeling for Kræftbehandling Herlev 2730 Denmark Details
Clinica Universitaria de Navarra Pamplona Navarra 31008 Spain Details
Vall d´Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Oncología Madrid 28027 Spain Details
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field